Somatropin (rDNA origin, Merck Serono)

生长激素（默克雪兰诺）

Report date: 2025/03/27 20:00:06

Base Information

Drug NameSomatropin (rDNA origin, Merck Serono)
Drug Alias Name促生长激素（默克雪兰诺）Somatropine (rDNA origin, Merck Serono)Somatropinum (rDNA origin, Merck Serono)生长激素类（默克雪兰诺）Recombinant human growth hormone (rDNA origin, Merck Serono) +[13] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureFailure to Thrive +[10] 
Global Approved IndicationsGrowth hormone deficiencyShort Bowel Syndrome
Approved Indications in ChinaGrowth hormone deficiency
Original Approved Country/TerritoryUnited States
Original Approved Date1996/08/23
Country/TerritoryUnited StatesFranceBrazil +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono IncMerck Serono
Inactive CompaniesAzidus BrasilMerck Serono SasMerck KGaA, Darmstadt, Germany
Active IndicationsGrowth hormone deficiencyGrowth DisordersShort Bowel Syndrome
Inactive IndicationsIdiopathic short statureFailure to ThriveFibromyalgia +[7] 

Other Information

ATC CodeH01AC01
Related LinksDrugBankKEGG